Antibody Analytics

Antibody Analytics is a leading provider of testing services to support the discovery and characterisation of therapeutics in the oncology space. Built to empower drug developers from initial discovery throughout drug development to make better, more informed analytical decisions, Antibody Analytics pride themselves on taking their ‘late stage’ experience and applying it early to their customer’s discovery and preclinical pipelines.

Scientists turn to Antibody Analytics when they are looking to characterize their molecules in in vitro systems that model in vivo interactions. As the name suggests, the team have a lot of experience working with antibody-based therapies, however with their primary immune cell and binding capabilities, Antibody Analytics also support investigation and in vitro characterisation of small molecules, cell therapies and other biologic entities.